Azura Ophthalmics raises $28m for registration studies for treatment of leading cause of dry eye disease-PR Newswire APAC
- Written by PR Newswire
-- Medical Research Commercialisation Fund (MRCF) in raise for registration study to treat Meibomian gland dysfunction, the leading cause of Dry Eye Disease
-- Meibomian gland dysfunction affects more than 30 million adults in the United States alone - registration studies used to seek potential regulatory approval with the FDA
-- Financing also...
